Back
Vertex Pharmaceuticals Vs. Bristol-Myers Squibb Industry Stock Comparison
Sell
46
VRTX
Vertex Pharmaceuticals
Last Price:
$397.10
Seasonality Move:
6.89%
Sell
40
BMY
Bristol-Myers Squibb
Last Price:
$57.30
Seasonality Move:
1.66%
Sell
46
Vertex Pharmaceuticals (VRTX)
is a Sell
Is Vertex Pharmaceuticals a Buy, Sell or Hold?
-
The current Vertex Pharmaceuticals [VRTX] share price is $397.27. The Score for VRTX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
VRTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Bristol-Myers Squibb (BMY)
is a Sell
Is Bristol-Myers Squibb a Buy, Sell or Hold?
-
The current Bristol-Myers Squibb [BMY] share price is $57.33. The Score for BMY is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
BMY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VRTX Stock Price Chart
What is Vertex Pharmaceuticals's stock price today?
-
The Vertex Pharmaceuticals share price today is $397.27Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRTX is experiencing slight buying pressure.
BMY Stock Price Chart
What is Bristol-Myers Squibb's stock price today?
-
The Bristol-Myers Squibb share price today is $57.33Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BMY is experiencing buying pressure, which is a positive indicator for future bullish movement.
VRTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -11.99 | Sell |
Relative Strength Index (14 RSI): | 24.09 | Sell |
Chaikin Money Flow: | 2740027 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (437.81 - 475.91) | Sell |
Bollinger Bands (100): | (455.22 - 489.42) | Sell |
BMY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.03 | Buy |
Relative Strength Index (14 RSI): | 51.02 | Buy |
Chaikin Money Flow: | 45046909 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (56.68 - 59.08) | Sell |
Bollinger Bands (100): | (48.85 - 56.81) | Buy |
VRTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 446.86 | Sell |
20-day SMA: | 456.96 | Sell |
50-day SMA: | 470.34 | Sell |
200-day SMA: | 457.21 | Sell |
8-day EMA: | 436.6 | Sell |
20-day EMA: | 452.97 | Sell |
50-day EMA: | 463.97 | Sell |
200-day EMA: | 453.34 | Sell |
BMY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 56.59 | Buy |
20-day SMA: | 57.98 | Sell |
50-day SMA: | 56.11 | Buy |
200-day SMA: | 49.22 | Buy |
8-day EMA: | 57.01 | Buy |
20-day EMA: | 57.29 | Buy |
50-day EMA: | 55.96 | Buy |
200-day EMA: | 52.03 | Buy |
Vertex Pharmaceuticals Earnings Growth & VRTX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.74 per share, a decrease next quarter of $0.00 per share, a decrease this year of $14.53 per share, and an increase next year of $18.29 per share.
Bristol-Myers Squibb Earnings Growth & BMY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.37 per share, a decrease next quarter of $0.00 per share, a decrease this year of $6.48 per share, and an increase next year of $6.17 per share.
Vertex Pharmaceuticals Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Bristol-Myers Squibb Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |